Concepedia

Hitomi Ogino

HO

Statistics

Publications

8

Citations

236

H-Index

8

Active since

2011

Affiliations

Takeda (Japan)(Current)

Takeda (United States)

Hitomi Ogino is an author at Takeda (Japan) specializing in pharmacology, receptor pharmacology, and medicinal chemistry.

Publications per year

2011–2020

8

Publications

8

Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis

Emma L. Shepherd, Raquel Saborano, Ellie Northall et al. · JHEP Reports · 2020 · 67 citations · Full text

, , +17

Acetyl-CoA carboxylase 1 and 2 inhibition ameliorates steatosis and hepatic fibrosis in a MC4R knockout murine model of nonalcoholic steatohepatitis

Mitsuharu Matsumoto, Hiroaki Yashiro, Hitomi Ogino et al. · PLoS ONE · 2020 · 38 citations · Full text

, , +17

SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity

Hikaru Ueno, Ryo Ito, Shinichi Abe et al. · Journal of Pharmacology and Experimental Therapeutics · 2019 · 36 citations · Full text

, , +17

Melanin-Concentrating Hormone Receptor 1 Antagonists. Synthesis and Structure–Activity Relationships of Novel 3-(Aminomethyl)quinolines

Makoto Kamata, Toshiro Yamashita, Toshihiro Imaeda et al. · Journal of Medicinal Chemistry · 2012 · 31 citations · Full text

, , +15

GPR40 full agonism exerts feeding suppression and weight loss through afferent vagal nerve

Hikaru Ueno, Ryo Ito, Shinichi Abe et al. · PLoS ONE · 2019 · 21 citations · Full text

, , +16

1–5 of 8